Overview

Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea

Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
This is a proof of concept study to determine the safety and efficacy of dronabinol for the treatment of obstructive sleep apnea syndrome (OSA).
Phase:
Phase 2
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborators:
Hektoen Institute for Medical Research
National Heart, Lung, and Blood Institute (NHLBI)
Northwestern University
University of Chicago
Treatments:
Dronabinol